◆ 会议时间:2025年4月1-5日
◆ 会议地点:奥地利 维也纳
◆ 会议简介:
2025年国际阿尔茨海默病与帕金森病及相关神经系统疾病大会(AD/PD2025)将于2025年4月1-5日在奥地利维也纳举行。AD/PD会议旨在为国际医学和科学届的专业人士提供更好的机会,以讨论阿尔茨海默病、帕金森病和其他相关神经系统疾病的治疗、转化研发、早期诊断、药物开发和临床试验方面的最新突破。会议将是提示阿尔茨海默病、帕金森病和其他相关神经退行性疾病的机制并改善其治疗方法宣的最前沿。AD/PD会议独特地将不同的神经退行性疾病结合在一起,并研究它们的异同点,重点是疾病的机制、预防和治疗。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。
International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders - AD/PD 2025
Date:
April 1-5, 2025
Venue:
Vienna, Austria
Language:
The official language of the conference is English.
摘要征文投稿:
Abstract Submission Open |
May, 2024 |
Abstract Submission Deadline |
September 19, 2024 |
Abstract Submission Notifications |
Mid-November, 2024 |
点此提交摘要>>>Submit Abstract>>>
ABSTRACT TOPICS
RULES FOR SUBMISSION OF ABSTRACTS
Abstracts must be submitted via this website. Faxed or emailed abstracts will not be considered.
Please read the submission rules before submitting an abstract.
- Please note each participant may present a maximum of 5 posters and/or 1 Oral presentation. There is no limit to the amount of abstracts one person may submit. The system will count the amount of presentations from all submissions and notify you if the person you would like to assign as presenter has reached the maximum 5 presentations. Submitters and co-authors can be listed on as many abstracts as needed.
- The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.
- The presenting author must be listed as the first author.
- Submitted abstracts should include non-published data.
- Abstracts previously presented will not be accepted.
- All abstracts should be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university specific publications office (or other similar facility) or by a copy editor, prior to submission.
- Please submit symbols as words.
- All abstracts accepted for presentation will be published on the Conference website prior to the Conference.
- You may submit more than 1 abstract. However, presenters that are accepted for oral presentation will be permitted to give only 1 oral presentation. Additional accepted abstracts will therefore be poster only.
- Please note the submitting author will receive all correspondence about the abstract so we advise that the submitting author details that are entered are the same details as those of the presenting author.
- Eligible candidates for Junior Faculty Awards are graduate students (PhD, MD) or junior scientists up to five years after the doctorate degree (PhD, MD). Please note this is not applicable for Late Breaking as winners have already been announced.
- Please ensure that if you are submitting an abstract to be considered for the Junior Faculty Award that you upload all relevant supporting documents when you submit the abstract. Please note this is not applicable for Late Breaking as winners have already been announced.
- Abstracts may not be edited/updated after final submission. You are welcome to bring an updated abstract onsite with you.
- Your abstract is not successfully submitted until you receive a confirmation e-mail after clicking the final submit button. If you do not receive a confirmation e-mail, please contact us.
GUIDELINES FOR SUBMISSION
Before you begin, please prepare the following information:
Abstract Topic – abstracts must be allocated to a specific Theme, Topic and Sub-Topic.
Presenting author’s contact details (should be the same details as the submitting author so that the presenting author receives the correspondence about the abstract):
- Email address
- Full postal address
- Daytime and evening phone number
- Author and co-authors’ details
- Full first and family name(s)
- Affiliation details: department, institution / hospital, city, state (if relevant), country
- Abstract title – limited to 20 words in UPPER CASE
- Abstract text – limited to 280 words (Please Note: Word count is affected when graphs/tables/images are added)
- Abstract layout – Abstracts must be submitted with the following sections: Objectives, Methods, Results, Conclusions
- References are not obligatory and word count is affected by inclusion of references.
Tables – Tables created by using the table button will count each word used.
Graphs – The maximum file size of each graph/image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload graphs in JPG format only. Images do not count towards the word limit.
You can save drafts of abstracts, but you must final submit the abstract before the deadline in order for it to be successfully submitted. Drafts, not finally submitted by the deadline will not be accepted.
ABSTRACT SUBMITTERS’ DECLARATION
During abstract submission you will be asked to declare the following:
- I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published as submitted.
- Submission of the abstract constitutes the consent of all authors to publication (e.g. Conference website, programs, other promotions, etc.)
- The Abstract Submitter warrants and represents that no part of the information and content provided by him/her (Hereafter: the “Content“) to AD/PDTM 2025 and Kenes International (Hereafter: the “Organizers“), nor the publication of any such Content by the Organizers, on the internet or otherwise infringes any third party rights, including but not limited to privacy rights and/or intellectual property rights.
- The Abstract Submitter grants the Organizers a copyright license to reproduce, publish, translate, distribute, and display the text of the Content on a royalty-free, perpetual, irrevocable nonexclusive basis.
- I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract.
- I understand that the presenting author must be a registered participant.
- The Organizers reserve the right to remove from publication and/or presentation an abstract which does not comply with the above.
- I understand that I must select a specific Theme, Topic and Sub-Topic for my abstract allocation. Although the Committee will work hard to honor this selection, this cannot be guaranteed. The Committee reserves the right to change the Theme, Topic or Sub-Topic under which the abstract was originally submitted.
CONFLICT OF INTEREST & ETHICAL APPROVAL
You will be asked to declare that you have received ethical approval for your study (if relevant), and you will be requested to confirm that you will declare any conflict of interests in your presentation at the Conference.
ABSTRACT SELECTION AND PRESENTATION
The Committee will review all submitted abstracts. Notification regarding abstract acceptance and scheduling will be sent to the submitting author.
Please note, if your abstract is accepted for oral presentation, the presenting author will be permitted a maximum of 1 oral presentation in the CME accredited program.
Welcome Message
We invite you to join us at the upcoming AD/PD™ 2025 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders. The groundbreaking series of Alzheimer’s and Parkinson’s Diseases Conferences attract international medical and scientific professionals worldwide. The Conference remains at the forefront of unraveling the mechanisms and improving the treatment of Alzheimer’s, Parkinson’s, and other related neurodegenerative diseases. AD/PD™ Conferences uniquely combine distinct neurodegenerative diseases in one setting and examine their similarities and differences; a strong focus is mechanisms of disease, prevention, and therapy.
The AD/PD™ Conference has become the main event of the year in the field of neurodegenerative diseases, attracting leading medical and scientific professionals from around the world. AD/PD™ is now an annual meeting, with a continuing focus on the ADVANCES IN SCIENCE & THERAPY of Alzheimer’s and Parkinson’s Diseases and related neurological disorders.
The forthcoming AD/PD™ meeting, in 2025 will take place as a Hybrid Conference in the enchanting city of Vienna, Austria, and online. The continuing success of the AD/PD™ meetings is the result of several key ingredients:
- A high-quality scientific program covering most recent research, developments, and treatments, with emphasis on overlaps and congruent results among AD, PD, and related neurological disorders.
- A multidisciplinary mix of participants representing both clinical investigators and basic scientists; as well as both established investigators and young upcoming talents.
- An International Scientific Advisory Board covering a broad range of expertise in AD, PD, and related neurological disorders.
- A concerted attempt to provide an ambiance at the Conference that encourages interaction, exchange of ideas, and networking opportunities among all participants.
- Junior Faculty Awards, intended to encourage attendance by young scientists at the Conference.
The reason for the continuing success of the AD/PD™ meetings is their uniqueness, their academic quality combined with the interactive and collegial environment. We believe that there is no other conference in the world that presents such a high level of science in a condensed manner on one hand, yet on the other hand, provides an enormously comfortable atmosphere in which to enjoy it all. We invite you to join us at the AD/PD™ 2025 International Conference on AD and PD, and we hope to welcome you in the Spring of 2025, in Vienna or online.
Abraham Fisher, Ph.D.
President
Ezio Giacobini, M.D.
Executive Organizer
Gabriel Gold, M.D.
Executive Organizer
Cynthia Lemere, Ph.D.
Executive Organizer
Henrietta Nielsen, Ph.D.
Executive Organizer
Roger M. Nitsch, M.D.
Executive Organizer
Manfred Windisch, Ph.D.
Executive Organizer
注册费:
Registration category |
Early rate
Until December 18, 2024 |
Regular rate
From December 19, 2024 - March 4, 2025 |
Onsite rate
From March 5, 2025 |
Regular Track |
Gold Track |
Regular Track |
Gold Track |
Regular Track |
Gold Track |
In-person (Onsite) Participation |
Full participant - (physical) |
€ 925 |
€1,045 |
€ 990 |
€ 1,110 |
€ 1,105 |
€1,225 |
Low & Lower-middle income countries ** |
€ 570 |
€670 |
€ 670 |
€ 770 |
€ 720 |
€ 820 |
Trainee *(Student/Nurse/Fellow) |
€ 400 |
€ 500 |
€ 450 |
€ 550 |
€ 500 |
€ 600 |
Online (Virtual) Participation Only |
Full participant |
€ 450 |
€ 570 |
€ 450 |
€ 570 |
€ 500 |
€ 620 |
Trainee *(Student/Nurse/Fellow) |
€ 300 |
€ 400 |
€ 300 |
€ 400 |
€ 350 |
€ 450 |
*Trainee (Student/Fellow/Nurses) – status must be certified – An official supportive letter from the institution, signed by the head of the department confirming your status, or a valid status ID card must accompany the registration.
**Low & Lower-middle income countries are defined according to the World Bank Country Classification; click here to see the Country Classification data.
In Person Attendance Conference Package for Participants:
The AD/PD™ 2025 Conference will offer you a full hybrid experience and the opportunity to take part in every aspect of the Conference including:
- Participation in all scientific sessions.
- Printed material of the Conference.
- An invitation to the Welcome Reception.
- Entrance to the Exhibition and Poster Area.
- Conference refreshments as per breaks indicated in the program.
- Open access to the AD/PD™ Virtual Platform where participants will be able to view presentations and session recordings whenever and wherever they choose during the Conference days and access e-posters.
Online Attendance Conference Package for Participants:
The AD/PD™ 2025 Conference will offer you a full virtual experience and the opportunity to take part in every aspect of the program including:
- Open access to presentations and session recordings. Create your own schedule, attend any and all of the sessions whenever and wherever you choose.
- Network with colleagues. Browse a list of participants and click on their name to contact them.
- Earn CME credits attributed to the AD/PD™ 2025 Conference.
- Access all the e-posters. Browse research on the hottest topics published in the online Journal of the Neurological Sciences and connect with the abstract authors and other colleagues from around the world through the e-poster virtual consultations.
- Join the debate. During live-streamed or recorded sessions, participate in live conversations with delegates from all over the world.
- Visit the virtual exhibition hall.
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|